The pathophysiology of intestinal lipoprotein production

Frontiers in Physiology

Volumn 6, Issue MAR, 2015, Pages

  Giammanco, Antonina ^a   Cefalù, Angelo B ^a   Noto, Davide ^a   Averna, Maurizio R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Assembly; Chylomicron; Inherited disorders; Secretion; Triglyceride rich lipoproteins

Indexed keywords

ACYLGLYCEROL LIPASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHYLOMICRON; COATOMER PROTEIN; FATTY ACID BINDING PROTEIN 2; GLUCAGON LIKE PEPTIDE 1; INCRETIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOMITAPIDE; LONG CHAIN FATTY ACID; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PROTEOHEPARAN SULFATE; SNARE PROTEIN; SORTILIN; SYNAPTOBREVIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL RICH LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ABETALIPOPROTEINEMIA; ALPHA TOCOPHEROL DEFICIENCY; BIOGENESIS; CATALYSIS; ENDOPLASMIC RETICULUM; FAMILIAL HYPERCHOLESTEROLEMIA; FAT INTAKE; GENE MUTATION; GOLGI COMPLEX; HUMAN; HYDROLYSIS; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 1; HYPOBETALIPOPROTEINEMIA; INSULIN RELEASE; INTESTINE CELL; LIPID ABSORPTION; LIPID DIET; LIPOPROTEIN METABOLISM; PATHOPHYSIOLOGY; PROTEIN ASSEMBLY; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN TRANSPORT; RETINOL DEFICIENCY; REVIEW; STEATORRHEA; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

EID: 84926507418     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00061     Document Type: Review

References (123)

1. Abumrad, N. A., and Davidson, N. O. (2012). Role of the gut in lipid homeostasis. Physiol. Rev . 92, 1061-1085. doi: 10.1152/physrev.00019.2011
2. Abumrad, N. A., el-Maghrabi, M. R., Amri, E. Z., Lopez, E., and Grimaldi, P. A. (1993). Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD 36. J. Biol. Chem . 268, 17665-17668.
3. Anderson, C. M., Townley, R. R., Freemanm, and Johansen, P. (1961). Unusual causes of steatorrhea in infancy and childhood. Med. J. Aust . 11, 617-622.
4. Apfelbaum, T. F., Davidson, N. O., and Glickman, R. M. (1987). Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am. J. Physiol. Gastrointest. Liver Physiol . 252, G662-G666.
5. Auwerx, J. H., Babirak, S. P., Fujimoto, W. Y., Iverius, P. H., and Brunzell, J. D. (1989). Defective enzyme protein in lipoprotein lipase deficiency. Eur. J. Clin. Invest . 19, 433-437. doi: 10.1111/j.1365-2362.1989.tb00255.x
6. Babirak, S. P., Iverius, P. H., Fujimoto, W. Y., and Brunzell, J. D. (1989). Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 9, 326-334. doi: 10.1161/01.ATV.9.3.326
7. Barlowe, C., Orci, L., Yeung, T., Hosobuchi, M., Hamamoto, S., Salama, N., et al. (1994). COPII: a membrane coat formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell 77, 895-907. doi: 10.1016/0092-8674(94)90138-4
8. Beigneux, A., Franssen, R., Bensadoun, A., Gin, P., Melford, K., Peter, J., et al. (2009). Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler. Thromb. Vasc. Biol . 29, 956-962. doi: 10.1161/ATVBAHA.109.186577
9. Beigneux, A. P., Davies, B. S., Gin, P., Weinstein, M. M., Farber, E., Qiao, X., et al. (2007). Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab . 5, 279-291. doi: 10.1016/j.cmet.2007.02.002
10. Berriot-Varoqueaux, N. (2004). Anderson's Disease (Chylomicron Retention Disease). Encyclopedia of Endocrine Diseases , Vol. 1. Amsterdam: Elsevier Inc. doi: 10.1016/B0-12-475570-4/00289-4
11. Black, D. D. (2007). Development and physiological regulation of intestinal lipid absorption. I. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion. Am. J. Physiol. Gastrointest. Liver Physiol . 293, G519-G524. doi: 10.1152/ajpgi.00189.2007
12. Breckenridge, W., Little, J. A., Steiner, G., Chow, A., and Poapst, M. (1978). Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N. Engl. J. Med . 298, 1265-1273. doi: 10.1056/NEJM197806082982301
13. Brunzell, J. D., and Austin, M. A. (1989). Plasma triglyceride levels and coronary disease. N. Eng. J. Med . 320, 1273-1275. doi: 10.1056/NEJM198905113201910
14. Brunzell, J. D., and Fujimoto, W. Y. (1995). Body fat distribution and dyslipidemia. Am. J. Med . 99, 457-458, 1913-1932.
15. Cartwright, U., Plonné, D., and Higgins, J. A. (2000). Intracellular events in the assembly of chylomicrons in rabbit enterocytes. J. Lipid Res . 41, 1728-1739.
16. Cefalù, A. B., Calvo, P. L., Noto, D., Baldi, M., Valenti, V., Lerro, P., et al. (2010). Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene. Metab. Clin. Exp . 59, 463-467. doi: 10.1016/j.metabol.2009.07.042
17. Cefalù, A. B., Norata, G. D., Ghiglioni, D. G., Noto, D., Uboldi, P., Garlaschelli, K., et al. (2015). Homozygous familial hypobetalipoproteinemia: two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature. Atherosclerosis 239, 209-217. doi: 10.1016/j.atherosclerosis.2015.01.014
18. Charcosset, M., Sassolas, A., Peretti, N., Roy, C. C., Deslandres, C., Sinnett, D., et al. (2008). Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and functionality of Sar1b protein. Mol. Genet. Metab . 93, 74-84. doi: 10.1016/j.ymgme.2007.08.120
19. Cheng, C. F., Oosta, G. M., Bensadoun, A., and Rosenberg, R. D. (1981). Binding of lipoprotein lipase to endothelial cells in culture. J. Biol. Chem . 256, 12893-12898.
20. Chen, Z., and Davidson, N. O. (2012). IRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis. Cell Metab . 16, 473-486. doi: 10.1016/j.cmet.2012.09.003
21. Coburn, C. T., Knapp, F. F. Jr., Febbraio, M., Beets, A. L., Silverstein, R. L., and Abumrad, N. A. (2000). Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem . 275, 32523-32529. doi: 10.1074/jbc.M003826200
22. Cohen, R. D., Castellani, L. W., Qiao, J. H., Van Lenten, B. J., Lusis, A. J., and Reue, K. (1997). Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J. Clin. Invest . 99, 1906-1916. doi: 10.1172/JCI119358
23. Cuchel, M., Meagher, E. A., du Toit Theron, H., Blom, D. J., Marais, A. D., and Hegele, R. A. (2013). Phase 3 HoFH Lomitapide Study investigators. Efficacy and safety of amicrosomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Lancet 381, 40-46. doi: 10.1016/S0140-6736(12)61731-0
24. Culnan, D. M., Cooney, R. N., Stanley, B., and Lynch, C. J. (2009). Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity (Silver. Spring) . 17, 46-52. doi: 10.1038/oby.2008.428
25. Cupp, M., Bensadoun, A., and Melford, K. (1987). Heparin decreases the degradation rate of lipoprotein lipase in adipocytes. J. Biol. Chem . 262, 6383-6388.
26. Dash, S., Xiao, C., Morgantini, C., Connelly, P. W., Patterson, B. W., and Lewis, G. F. (2014). Glucagon-like peptide-2 regulates release of chylomicrons from the intestine. Gastroenterology 147, 1275-1284. doi: 10.1053/j.gastro.2014.08.037
27. Davidson, N. O., and Shelness, G. S. (2000). APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation. Ann. Rev. Nutr . 20, 169-193. doi: 10.1146/annurev.nutr.20.1.169
28. Davies, B. S., Beigneux, A. P., Barnes, R. H. II, Tu, Y., Gin, P., Weinstein, M. M., et al. (2010). GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab . 12, 42-52. doi: 10.1016/j.cmet.2010.04.016
29. Di Filippo, M., Marçais, C., Charrière, S., Marmontel, O., Broyer, M., Delay, M., et al. (2014). Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects. PLoS ONE 9:e99721. doi: 10.1371/journal.pone.0099721
30. Drover, V. A., Ajmal, M., Nassir, F., Davidson, N. O., Nauli, A. M., Sahoo, D., et al. (2005). CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J. Clin. Invest . 115, 1290-1297. doi: 10.1172/JCI21514
31. Drover, V. A., Nguyen, D. V., Bastie, C. C., Darlington, Y. F., Abumrad, N. A., Pessin, J. E., et al. (2008). CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice. J. Biol. Chem . 283, 13108-13115. doi: 10.1074/jbc.M708086200
32. Drucker, D. J. (2001). The glucagon-like peptides. Endocrinology 142, 521-527. doi: 10.1210/endo.142.2.7983
33. Duverger, N., Tremp, G., Caillaud, J. M., Emmanuel, F., Castro, G., Fruchart, J. C., et al. (1996). Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 273, 966-968. doi: 10.1126/science.273.5277.966
34. Dvorin, E., Gorder, N. L., Benson, D. M., and Gotto, A. M. Jr. (1986). Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J. Biol. Chem . 261, 15714-15718.
35. Elshourbagy, N. A., Walker, D. W., Paik, Y. K., Boguski, M. S., Freeman, M., Gordon, J. I., et al. (1987). Structure and expression of the human apolipoprotein A-IV gene. J. Biol. Chem . 262, 7973-7981.
36. Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., and Protter, A. A. (1993). CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem . 268, 11811-11816.
37. Estall, J. L., and Drucker, D. J. (2006). Glucagon-like peptide-2. Annu. Rev. Nutr . 26, 391-411. doi: 10.1146/annurev.nutr.26.061505.111223
38. Fisher, E. A., Pan, M., Chen, X., Wu, X., Wang, H., Jamil, H., et al. (2001). The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J. Biol. Chem . 276, 27855-27863. doi: 10.1074/jbc.M008885200
39. Fujimoto, K., Cardelli, J. A., and Tso, P. (1992). Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am. J. Physiol. Gastrointest. Liver Physiol . 262, G1002-G1006.
40. Golberg, C. A. (2013). Emerging low-density lipoprotein therapies: microsomal triglyceride transfer protein inhibitors. J. Clin. Lipidol . 7(3 Suppl.), S16-S20. doi: 10.1016/j.jacl.2013.03.003
41. Gonzales, J. C., Gordts, P. L., Foley, E. M., and Esko, J. D. (2013). Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. J. Clin. Invest . 123, 2742-2751. doi: 10.1172/JCI67398
42. Green, P. H., Glickman, R. M., Riley, J. W., and Quinet, E. (1980). Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J. Clin. Invest . 65, 911-919. doi: 10.1172/JCI109745
43. Greenwalt, D. E., Scheck, S. H., and Rhinehart-Jones, T. (1995). Heart CD 36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J. Clin. Invest . 96, 1382-1388. doi: 10.1172/JCI118173
44. Gusarova, V., Brodsky, J. L., and Fisher, E. A. (2003). Apolipoprotein B-100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER. J. Biol. Chem . 278, 48051-48058. doi: 10.1074/jbc.M306898200
45. Haghpassand, M., Wilder, D., and Moberly, J. B. (1996). Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2). J. Lipid Res . 37, 1468-1480.
46. Hajri, T., Han, X. X., Bonen, A., and Abumrad, N. A. (2002). Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J. Clin. Invest . 109, 1381-1389. doi: 10.1172/JCI0214596
47. Hamilton, J. A. (2004). Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us. Prog. Lipid Res . 43, 177-199. doi: 10.1016/j.plipres.2003.09.002
48. Hamilton, R. L. (1972). Synthesis and secretion of plasma lipoproteins. Adv. Exp. Med. Biol . 26, 7-24. doi: 10.1007/978-1-4684-7547-0_2
49. Hayashi, H., Nutting, D. F., Fujimoto, K., Cardelli, J. A., Black, D., and Tso, P. (1990). Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J. Lipid Res . 31, 1613-1625.
50. Hegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., et al. (2013). The polygenic nature of hypertriglyceridemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol . 8587, 70191-70198. doi: 10.1016/S2213-8587(13)70191-8
51. Hein, G. J., Baker, C., Hsieh, J., Farr, S., and Adeli, K. (2013). GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2 stimulated post-prandial lipemia in normal and insulin-resistent states. Diabetes 62, 373-381. doi: 10.2337/db12-0202
52. Hirano, K., Kuwasako, T., Nakagawa-Toyama, Y., Janabi, M., Yamashita, S., Matsuzawa, Y., et al. (2003). Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc. Med . 13, 136-141. doi: 10.1016/S1050-1738(03)00026-4
53. Hsieh, J., Hayashi, A. A., Webb, J., and Adeli, K. (2008). Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity. Atheroscl. Suppl . 9, 97-13. doi: 10.1016/j.atherosclerosissup.2008.09.422
54. Hsieh, J., Longuet, C., Baker, C. L., Qin, B., Federico, L. M., and Drucker, D. J. (2010). The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamster and mice. Diabetologia 53, 552-561. doi: 10.1007/s00125-009-1611-5
55. Hussain, M. M. (2000). A proposed model for the assembly of chylomicrons. Atherosclerosis 148, 1-15. doi: 10.1016/S0021-9150(99)00397-4
56. Hussain, M. M., Fatma, S., Pan, X., and Iqbal, J. (2005). Intestinal lipoprotein assembly. Curr. Opin. Lipidol . 16, 281-285. doi: 10.1097/01.mol.0000169347.53568.5a
57. Hussain, M. M., Rava, P., Walsh, M., Rana, M., and Iqbal, J. (2012). Multiple functions of microsomal triglyceride transfer protein. Nutr. Metab. (Lond) . 9:14. doi: 10.1186/1743-7075-9-14
58. Ikonen, E. (2008). Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol . 9, 125-138. doi: 10.1038/nrm2336
59. Johansen, C. T., Kathiresan, S., and Hegele, R. A. (2011). Genetic determinants of plasma triglycerides. J. Lipid Res . 52, 189-206. doi: 10.1194/jlr.R009720
60. Jones, B., Jones, E. L., Bonney, S. A., Patel, H. N., Mensenkamp, A. R., Eichenbaum-Voline, S., et al. (2003). Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat. Genet . 34, 29-31. doi: 10.1038/ng1145
61. Kalogeris, T. J., Qin, X., Chey, W. Y., and Tso, P. (1998). PYY stimulates synthesis and secretion of intestinal apolipoprotein A-IV without affecting mRNA expression. Am. J. Physiol. Heart Circ. Physiol . 274, H1836-H1840.
62. Kalogeris, T. J., Rodriguez, M. D., and Tso, P. (1997). Control of synthesis and secretion of intestinal apolipoprotein A-IV by lipid. J. Nutr . 127, 537S-543S.
63. Kalogeris, T. J., Tsuchiya, T., Fukagawa, K., Wolf, R., and Tso, P. (1996). Apolipoprotein A-IV synthesis in proximal jejunum is stimulated by ileal lipid infusion. Am. J. Physiol. Gastrointest. Liver Physiol . 270, G277-G286.
64. Kane, J. P. (1989). The Metabolic Basis of Inherited Disease, 6th Edn , ed C. R. Scriver. New York, NY: Mc Graw-Hill. 1345.
65. Khosrow, A., and Lewis, G. F. (2008). Intestinal lipoprotein overproduction in insulin-resistant states. Curr. Opin. Lipid . 19, 221-228. doi: 10.1097/MOL.0b013e3282ffaf82
66. Klingenberg, R., Gerdes, N., Badeau, R. M., Gisterå, A., Strodthoff, D., Ketelhuth, D. F., et al (2013). Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J. Clin. Invest . 123, 1323-1334. doi: 10.1172/JCI63891
67. Kohan, A. B., Wang, F., Li, X., Bradshaw, S., Yang, Q., Caldwell, J. L., et al. (2012). Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function. Am. J. Physiol. Gastrointest. Liver Physiol . 302, G628-G636. doi: 10.1152/ajpgi.00225.2011
68. Kohan, A. B., Wang, F., Li, X., Vandersall, A. E., Huesman, S., Xu, M., et al. (2013). Is apolipoprotein A-IV rate limiting in the intestinal transport and absorption of triglyceride? Am. J. Physiol. Gastrointest. Liver Physiol . 304, G1128-G1135. doi: 10.1152/ajpgi.00409.2012
69. Kumar, N. S., and Mansbach, C. M. II. (1999). Prechylomicron transport vesicle: isolation and partial characterization. Am. J. Physiol . 276, G378-G386.
70. Lee, J., and Hegele, R. A. (2014). Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management. J. Inherit. Metab. Dis . 37, 333-339. doi: 10.1007/s10545-013-9665-4
71. Levy, E., Stan, S., Delvin, E., Menard, D., Shoulders, C., Garofalo, C., et al. (2002). Localization of microsomal triglyceride transfer protein in the Golgi: possible role in the assembly of chylomicrons. J. Biol. Chem . 277, 16470-16477. doi: 10.1074/jbc.M102385200
72. Liang, J. S., Wu, X., Fisher, E. A., and Ginsberg, H. N. (2000). The amino-terminal domain of apolipoprotein B does not undergo retrograde translocation from the endoplasmic reticulum to the cytosol. Proteasomal degradation of nascent apolipoprotein B begins at the carboxyl terminus of the protein, while apolipoprotein B is still in its original translocon. J. Biol. Chem . 275, 32003-32010. doi: 10.1074/jbc.M004646200
73. Love-Gregory, L., Sherva, R., Schappe, T., Qi, J. S., McCrea, J., Klein, S., et al. (2011). Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum. Mol. Genet . 20, 193-201. doi: 10.1093/hmg/ddq449
74. Lu, S., Yao, Y., Cheng, X., Mitchell, S., Leng, S., Meng, S., et al. (2006). Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size. J. Biol. Chem . 281, 3473-3483. doi: 10.1074/jbc.M502501200
75. Ma, X., Bacci, S., Mlynarski, W., Gottardo, L., Soccio, T., Menzaghi, C., et al. (2004). A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum. Mol. Genet . 13, 2197-2205. doi: 10.1093/hmg/ddh233
76. Mansbach, C. M., and Gorelick, F. S. (2007). Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. Am. J. Physiol. Gastrointest. Liver Physiol . 293, G645-G650. doi: 10.1152/ajpgi.00299.2007
77. Mansbach, C. M., and Siddiqi, S. A. (2010). The biogenesis of chylomicrons. Annu. Rev. Physiol . 72, 315-333. doi: 10.1146/annurev-physiol-021909-135801
78. Marcais, C., Verges, B., Charrière, S., Pruneta, V., Merlin, M., Billon, S., et al. (2005). Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J. Clin. Invest . 115, 2862-2869. doi: 10.1172/JCI24471
79. Matikainen, N., and Taskinen, M. R. (2013). The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes. Diabet. Med . 30, 756-757. doi: 10.1111/dme.12094
80. Meier, J. J., Nauck, M. A., Pott, A., Heinze, K., Goetze, O., Bulut, K., et al. (2006). Glucagon-like peptide-2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 130, 44-54. doi: 10.1053/j.gastro.2005.10.004
81. Mendoza-Barbera, E., Julve, J., Nilsson, S. K., Lookene, A., Martín-Campos, J. M., Roig, R., et al. (2013). Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia. J. Lip. Res . 54, 649-661. doi: 10.1194/jlr.M031195
82. Monsalve, M. V., Henderson, H., Roederer, G., Julien, P., Deeb, S., Kastelein, J. J., et al. (1990). A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries. J. Clin. Invest . 86, 728-734. doi: 10.1172/JCI114769
83. Neeli, I., Siddiqi, S. A., Siddiqi, S., Mahan, J., Lagakos, W. S., Binas, B., et al. (2007). Liver fatty acid-binding protein initiates budding of pre-chylomicron transport vesicles from intestinal endoplasmic reticulum. J. Biol. Chem . 282, 17974-17984. doi: 10.1074/jbc.M610765200
84. Newberry, E. P., Xie, Y., Kennedy, S. M., Luo, J., and Davidson, N. O. (2006). Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 44, 1191-1205. doi: 10.1002/hep.21369
85. Ohta, T., Fidge, N. H., and Nestel, P. J. (1985). Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph. J. Clin. Invest . 76, 1252-1260. doi: 10.1172/JCI112081
86. Ojakian, R. P., Ojakian, G. K., Shelness, G. S., and Hussain, M. M. (2006). Phospholipid transfer activity of microsomal triacylglycerol transfer protein is sufficient for the assembly and secretion of apolipoprotein B lipoproteins. J. Biol. Chem . 281, 11019-11027. doi: 10.1074/jbc.M512823200
87. Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C., Cox, D. R., Fruchart, J. C., et al. (2001). An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169-173. doi: 10.1126/science.1064852
88. Peterfy, M., Ben-Zeev, O., Mao, H. Z., Weissglas-Volkov, D., Aouizerat, B. E., Pullinger, C. R., et al. (2007). Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat. Genet . 39, 1483-1487. doi: 10.1038/ng.2007.24
89. Priore, O., Pisciotta, L., Li Volti, G., Sambataro, M. P., Cantafora, A., Bellocchio, A., et al. (2005). Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol . 25, 411-417. doi: 10.1161/01.ATV.0000153087.36428.dd
90. Qin, X., Shen, H., Liu, M., Yang, Q., Zheng, S., Sabo, M., et al. (2005). GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats. Am. J. Physiol. Gastrointest. Liver Physiol . 288, G943-G949. doi: 10.1152/ajpgi.00303.2004
91. Schonfeld, G. (2003). Familial hypobetalipoproteinemia: a review. J. Lipid Res . 44, 878-883. doi: 10.1194/jlr.R300002-JLR200
92. Shoulders, C. C., Jones, B., Duncan, E. J., Hutchison, C. E., Ozkan, T., Williams, P. A., et al. (2014). The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis. J. Biol. Chem . 289, 4244-4261. doi: 10.1074/jbc.M113.479980
93. Shoulders, C. C., Stephens, D. J., and Jones, B. (2004). The intracellular transport of chylomicrons requires the small GTPase, Sar1b. Curr. Opin. Lipidol . 15, 191-197. doi: 10.1097/00041433-200404000-00012
94. Siddiqi, S. A., Gorelick, F. S., Mahan, J. T., and Mansbach, C. M. II. (2003). In vitro budding of pre-chylomicron transport vesicles from the endoplasmic reticulum is COPII protein independent. J. Cell Sci . 116, 415-427. doi: 10.1242/jcs.00215
95. Siddiqi, S. A., Saleem, U., Abumrad, N. A., Davidson, N. O., Storch, J., Siddiqi, S. A., et al. (2010a). A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER. J. Lip. Res . 51, 1918-1928. doi: 10.1194/jlr.M005611
96. Siddiqi, S. A., Siddiqi, S. A., and Mansbach, C. M. II. (2010b). Sec24C is required for docking the prechylomicron transport vesicle with the Golgi. J. Lip. Res . 51, 1093-1100. doi: 10.1194/jlr.M002758
97. Siddiqi, S. A., Siddiqi, S., Mahan, J., Peggs, K., Gorelick, F. S., and Mansbach, C. M. II. (2006). The identification of a novel endoplasmic reticulum to Golgi SNARE complex used by the prechylomicron transport vesicle. J. Biol. Chem . 281, 20974-20982. doi: 10.1074/jbc.M601401200
98. Silverstein, R. L., and Febbraio, M. (2009). CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal . 26:re3. doi: 10.1126/scisignal.272re3
99. Stein, O., Stein, Y., Lefevre, M., and Roheim, P. S. (1986). The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochem. Biophys. Acta 878, 7-13. doi: 10.1016/0005-2760(86)90337-1
100. Storch, J., and Thumser, A. E. (2010). Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem . 285, 32679-32683. doi: 10.1074/jbc.R110.135210
101. Strich, D. R., Goldstein, R., Phillips, A., Shemer, R., Goldberg, Y., Razin, A., et al. (1993). Anderson's disease: no linkage to the apoB locus. J. Pediatr. Gastroenterol. Nutr . 16, 257-264. doi: 10.1097/00005176-199304000-00006
102. Strong, A., Patel, K., and Rader, D. J. (2014). Sortilin and lipoprotein metabolism:making sense out of complexity. Curr. Opin. Lipidol . 25, 350-357. doi: 10.1097/MOL.0000000000000110
103. Strong, A., and Rader, D. J. (2012). Sortilin as a regulator of lipoprotein metabolism. Curr. Atheroscler. Rep . 14, 211-218. doi: 10.1007/s11883-012-0248-x
104. Tarugi, P., and Averna, M. (2011). Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. Adv. Clin. Chem . 54, 81-107. doi: 10.1016/B978-0-12-387025-4.00004-2
105. Teslovich, T. M. I., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., et al. (2010). Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713. doi: 10.1038/nature09270
106. Tso, P., Drake, D. S., Black, D. D., and Sabesin, S. M. (1984). Evidence for separate pathways of chylomicron and very low-density lipoprotein assembly and transport by rat small intestine. Am. J. Physiol. Gastrointest. Liver Physiol . 247, G599-G610.
107. Tso, P., Liu, M., Kalogeris, T. J., and Thomson, A. B. (2001). The role of apolipoprotein A-IV in the regulation of food intake. Annu. Rev. Nutr . 21, 231-254. doi: 10.1146/annurev.nutr.21.1.231
108. Van der Vliet, H. N., Sammels, M. G., Leegwater, A. C., Levels, J. H., Reitsma, P. H., Boers, W., et al. (2001). Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J. Biol. Chem . 276, 44512-44520. doi: 10.1074/jbc.M106888200
109. Voshol, P. M., Minich, D. M., Havinga, R., Elferink, R. P., Verkade, H. J., Groen, A. K., et al. (2000). Postprandial chylomicron formation and fat absorption in multidrug resistence gene 2 P-glycoprotein-deficient mice. Gastroenterology 118, 173-182. doi: 10.1016/S0016-5085(00)70426-4
110. Vowinkel, T., Mori, M., Krieglstein, C. F., Russell, J., Saijo, F., Bharwani, S., et al. (2004). Apolipoprotein A-IV inhibits experimental colitis. J. Clin. Invest . 114, 260-269. doi: 10.1172/JCI200421233
111. Wang, F., Kohan, A. B., Kindel, T. L., Corbin, K. L., Nunemaker, C. S., Obici, S., et al. (2012). Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion. Proc. Natl. Acad. Sci. U.S.A . 109, 9641-9646. doi: 10.1073/pnas.1201433109
112. Watanabe, K., Ohta, Y., Toba, K., Ogawa, Y., Hanawa, H., Hirokawa, Y., et al. (1998). Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency. Ann. Nucl. Med . 12, 261-266. doi: 10.1007/BF03164911
113. Weinberg, R. B., Dantzker, C., and Patton, C. S. (1990). Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology 98, 17-24.
114. Wetterau, J. R., Lin, M. C., and Jamil, H. (1997). Microsomal triglyceride transfer protein. Biochim. Biophys. Acta 1435, 136-150. doi: 10.1016/S0005-2760(96)00168-3
115. Willnow, T. E., Kjølby, M., and Nykjaer, A. (2011). Sortilins: new players in lipoprotein metabolism. Curr. Opin. Lipidol . 22, 79-85. doi: 10.1097/MOL.0b013e3283416f2b
116. Wilson, D. E. (1990). Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J. Clin. Invest . 86, 735-750. doi: 10.1172/JCI114770
117. Wilson, D. E., Emi, M., Iverius, P. H., Hata, A., Wu, L. L., Hillas, E., et al. (1990). Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J. Clin. Invest . 86, 735-750. doi: 10.1172/JCI114770
118. Xiao, C., Dash, S., and Lewis, G. F. (2012). Mechanisms of incretin effects on plasma lipids and implications for the cardiovascular system. Cardiovasc. Hematol. Agents Med. Chem . 10, 289-294. doi: 10.2174/187152512803530315
119. Xiao, C., Dash, S., Morgantini, C., and Lewis, G. F. (2014). New and emerging regulators of intestinal lipoprotein secretion. Atherosclerosis 233, 608-615. doi: 10.1016/j.atherosclerosis.2013.12.047
120. Xiong, W., Li, W. H., Posner, I., Yamamura, T., Yamamoto, A., Gotto, A. M. Jr., et al. (1991). No severe bottleneck during human evolution: evidence from two apolipoprotein C-II deficiency alleles. Am. J. Hum. Genet . 48, 383-389.
121. Yamaguchi, J., Conlon, D. M., Liang, J. J., Fisher, E. A., and Ginsberg, H. N. (2006). Translocation efficiency of apolipoprotein B is determined by the presence of Β-sheet domains, not pause transfer sequences. J. Biol. Chem . 281, 27063-27071. doi: 10.1074/jbc.M606809200
122. Yamashita, S., Hirano, K., Kuwasako, T., Janabi, M., Toyama, Y., Ishigami, M., et al. (2007). Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Mol. Cell. Biochem . 299, 19-22. doi: 10.1007/s11010-005-9031-4
123. Zannis, V. I., Breslow, J. L., and Katz, A. J. (1980). Isoproteins of human apolipoprotein A-IV demonstrated in plasma and intestinal organ culture. J. Biol. Chem . 255, 8612-8617.